Broker spotlight – Shire, Glaxo, Barclays, William Hill, Kaz Minerals


Drug company Shire (LON:SHP) is in good health, Jefferies reckons. The stockbroker upped its target price on Shire shares this morning by 6% to 6150p and stuck with its ‘buy’ rating. It… [[ This…

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

http://ift.tt/1dzRkvw @MasterMetals MasterMetals Blog

from MasterMetals http://ift.tt/1JdYIX7

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s